231 related articles for article (PubMed ID: 22679243)
1. Serum antibodies to the heparin/platelet factor 4 complex are an independent predictor of thrombotic complications following pediatric fontan surgery.
Zhang R; Huang Y; Zhang M; Bai J; Liu J
Clin Appl Thromb Hemost; 2012 Sep; 18(5):448-52. PubMed ID: 22679243
[TBL] [Abstract][Full Text] [Related]
2. Thrombotic events in patients with antiplatelet factor 4/heparin antibodies.
Mattioli AV; Bonetti L; Carletti U; Ambrosio G; Mattioli G
Heart; 2009 Aug; 95(16):1350-4. PubMed ID: 19482851
[TBL] [Abstract][Full Text] [Related]
3. Incidence and clinical relevance of anti-platelet factor 4/heparin antibodies before cardiac surgery.
Selleng S; Malowsky B; Itterman T; Bagemühl J; Wessel A; Wollert HG; Warkentin TE; Greinacher A
Am Heart J; 2010 Aug; 160(2):362-9. PubMed ID: 20691844
[TBL] [Abstract][Full Text] [Related]
4. Heparin/PF4 antibodies formation after heparin treatment: temporal aspects and long-term follow-up.
Mattioli AV; Bonetti L; Zennaro M; Ambrosio G; Mattioli G
Am Heart J; 2009 Mar; 157(3):589-95. PubMed ID: 19249435
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery.
Everett BM; Yeh R; Foo SY; Criss D; Van Cott EM; Laposata M; Avery EG; Hoffman WD; Walker J; Torchiana D; Jang IK
Ann Thorac Surg; 2007 Feb; 83(2):592-7. PubMed ID: 17257993
[TBL] [Abstract][Full Text] [Related]
6. The incidence and implications of anti-heparin-platelet factor 4 antibody formation in a pediatric cardiac surgical population.
Mullen MP; Wessel DL; Thomas KC; Gauvreau K; Neufeld EJ; McGowan FX; Dinardo JA
Anesth Analg; 2008 Aug; 107(2):371-8. PubMed ID: 18633010
[TBL] [Abstract][Full Text] [Related]
7. A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients.
Demma LJ; Winkler AM; Levy JH
Anesth Analg; 2011 Oct; 113(4):697-702. PubMed ID: 21788317
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis.
Carrier M; Knoll GA; Kovacs MJ; Moore JC; Fergusson D; Rodger MA
Thromb Res; 2007; 120(2):215-20. PubMed ID: 17098277
[TBL] [Abstract][Full Text] [Related]
9. Heparin-dependent and -independent anti-platelet factor 4 autoantibodies in patients with systemic lupus erythematosus.
Satoh T; Tanaka Y; Okazaki Y; Kaburaki J; Ikeda Y; Kuwana M
Rheumatology (Oxford); 2012 Sep; 51(9):1721-8. PubMed ID: 22718864
[TBL] [Abstract][Full Text] [Related]
10. Heparin-platelet factor 4 antibodies are frequent after vascular surgery but are not a frequent cause of graft thrombosis or thrombocytopenia.
Alexy T; Tucker S; Boyle S; Rowe VL; Weaver FA; Liebman HA
J Vasc Surg; 2008 Aug; 48(2):377-81. PubMed ID: 18515040
[TBL] [Abstract][Full Text] [Related]
11. Physiological changes in membrane-expressed platelet factor 4: implications in heparin-induced thrombocytopenia.
Prechel MM; Jeske WP; Walenga JM
Thromb Res; 2010 Apr; 125(4):e143-8. PubMed ID: 19931120
[TBL] [Abstract][Full Text] [Related]
12. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.
Juhl D; Eichler P; Lubenow N; Strobel U; Wessel A; Greinacher A
Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of circuit and AV fistula clotting and detection of anti-PF4/heparin complex antibodies in hemodialysis patients suspected of having heparin-induced thrombocytopenia.
Matsuo T; Wanaka K; Walenga JM
Clin Appl Thromb Hemost; 2013; 19(1):73-8. PubMed ID: 22345486
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia.
Legnani C; Cini M; Pili C; Boggian O; Frascaro M; Palareti G
Thromb Haemost; 2010 Aug; 104(2):402-9. PubMed ID: 20539902
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases.
Amiral J; Bridey F; Wolf M; Boyer-Neumann C; Fressinaud E; Vissac AM; Peynaud-Debayle E; Dreyfus M; Meyer D
Thromb Haemost; 1995 Jan; 73(1):21-8. PubMed ID: 7740492
[TBL] [Abstract][Full Text] [Related]
16. Impact of heparin-induced thrombocytopenia on postoperative outcomes after cardiac surgery.
Kerendi F; Thourani VH; Puskas JD; Kilgo PD; Osgood M; Guyton RA; Lattouf OM
Ann Thorac Surg; 2007 Nov; 84(5):1548-53; discussion 1554-5. PubMed ID: 17954061
[TBL] [Abstract][Full Text] [Related]
17. Heparin-induced thrombocytopenia.
Fabris F; Luzzatto G; Stefani PM; Girolami B; Cella G; Girolami A
Haematologica; 2000 Jan; 85(1):72-81. PubMed ID: 10629596
[TBL] [Abstract][Full Text] [Related]
18. Role of platelet factor 4-heparin complex antibody (HIT antibody) in the pathogenesis of thrombotic episodes in patients on hemodialysis.
Nakamoto H; Shimada Y; Kanno T; Wanaka K; Matsuo T; Suzuki H
Hemodial Int; 2005 Oct; 9 Suppl 1():S2-7. PubMed ID: 16223438
[TBL] [Abstract][Full Text] [Related]
19. Incidence of heparin-PF4 complex antibody formation and heparin-induced thrombocytopenia in acute coronary syndrome.
Matsuo T; Tomaru T; Kario K; Hirokawa T;
Thromb Res; 2005; 115(6):475-81. PubMed ID: 15792678
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of heparin-induced thrombocytopenia in patients undergoing cardiac catheterization.
Foo SY; Everett BM; Yeh RW; Criss D; Laposata M; Van Cott EM; Jang IK
Am Heart J; 2006 Aug; 152(2):290.e1-7. PubMed ID: 16875910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
